- Home
- EDSA vs NIVF Comparison
EDSA vs NIVF Comparison
Compare EDSA & NIVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- NIVF
- Stock Information
- Founded
- EDSA 2015
- NIVF 2011
- Country
- EDSA Canada
- NIVF Hong Kong
- Employees
- EDSA N/A
- NIVF N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- NIVF
- Sector
- EDSA Health Care
- NIVF
- Exchange
- EDSA Nasdaq
- NIVF NYSE
- Market Cap
- EDSA 6.1M
- NIVF 5.2M
- IPO Year
- EDSA N/A
- NIVF N/A
- Fundamental
- Price
- EDSA $1.89
- NIVF $0.37
- Analyst Decision
- EDSA Strong Buy
- NIVF
- Analyst Count
- EDSA 1
- NIVF 0
- Target Price
- EDSA $21.00
- NIVF N/A
- AVG Volume (30 Days)
- EDSA 31.2K
- NIVF 5.4M
- Earning Date
- EDSA 02-07-2025
- NIVF 12-24-2024
- Dividend Yield
- EDSA N/A
- NIVF N/A
- EPS Growth
- EDSA N/A
- NIVF N/A
- EPS
- EDSA N/A
- NIVF N/A
- Revenue
- EDSA N/A
- NIVF $5,679,218.00
- Revenue This Year
- EDSA N/A
- NIVF N/A
- Revenue Next Year
- EDSA N/A
- NIVF N/A
- P/E Ratio
- EDSA N/A
- NIVF N/A
- Revenue Growth
- EDSA N/A
- NIVF N/A
- 52 Week Low
- EDSA $1.69
- NIVF $0.24
- 52 Week High
- EDSA $5.99
- NIVF $17.24
- Technical
- Relative Strength Index (RSI)
- EDSA 37.11
- NIVF 40.03
- Support Level
- EDSA $1.73
- NIVF $0.24
- Resistance Level
- EDSA $2.55
- NIVF $0.43
- Average True Range (ATR)
- EDSA 0.18
- NIVF 0.08
- MACD
- EDSA 0.03
- NIVF 0.01
- Stochastic Oscillator
- EDSA 25.58
- NIVF 28.50
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.